ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

NRXP Company Profile and Key Details

NASDAQ : NRXP

NRx Pharmaceuticals, Inc.

$2.17

0.01+0.46%

At Close 4:00 PM

$2.18

0.01+0.46%

After-Market 03:59 PM

62.77

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

NRXP Stock Price Chart

Stock Price Today

NRx Pharmaceuticals, Inc. (NRXP) stock surged +0.46%, trading at $2.17 on NASDAQ, up from the previous close of $2.16. The stock opened at $2.10, fluctuating between $2.09 and $2.21 in the recent session.

Stock Snapshot

2.16

Prev. Close

2.1

Open

36.71M

Market Cap

16.92M

Number of Shares

2.085

Day Low

2.205

Day High

-1.03

P/E Ratio

76.11%

Free Float in %

-2.11

EPS (TTM)

-0.14

Book Value

-0.26

Cash Flow per Share

125.99K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 07, 2025	2.14	2.21	2.05	2.17	126.01K
Mar 06, 2025	2.14	2.28	2.06	2.16	116.49K
Mar 05, 2025	2.15	2.15	2.03	2.14	128.15K
Mar 04, 2025	2.00	2.13	1.93	2.12	221.74K
Mar 03, 2025	2.31	2.35	1.84	2.03	467.07K
Feb 28, 2025	2.25	2.30	2.16	2.27	238.37K
Feb 27, 2025	2.42	2.46	2.26	2.29	130.24K
Feb 26, 2025	2.33	2.48	2.31	2.43	214.83K
Feb 25, 2025	2.43	2.51	2.21	2.33	257.55K
Feb 24, 2025	2.36	2.42	2.27	2.38	205.4K
Feb 21, 2025	2.43	2.49	2.25	2.28	322.84K
Feb 20, 2025	2.50	2.52	2.41	2.45	276.93K
Feb 19, 2025	2.75	2.82	2.49	2.54	377.62K
Feb 18, 2025	2.82	2.97	2.68	2.72	300.06K
Feb 14, 2025	2.93	3.07	2.82	2.85	281.62K
Feb 13, 2025	2.90	2.95	2.80	2.94	176.65K
Feb 12, 2025	3.06	3.07	2.91	2.94	154.5K
Feb 11, 2025	3.01	3.01	2.80	2.95	162.7K
Feb 10, 2025	2.92	3.13	2.91	3.03	256.03K
Feb 07, 2025	3.26	3.34	2.86	2.94	465.2K

Contact Details

Wilmington, DE 19801

United States

Website: https://www.nrxpharma.comContact: 484 254 6134

About Company

NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington, Delaware.

Frequently Asked Questions

What is the current NRx Pharmaceuticals, Inc. (NRXP) stock price?

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) stock price is $2.17 in the last trading session. During the trading session, NRXP stock reached the peak price of $2.21 while $2.09 was the lowest point it dropped to. The percentage change in NRXP stock occurred in the recent session was 0.46% while the dollar amount for the price change in NRXP stock was $0.01.

NRXP's industry and sector of operation?

The NASDAQ listed NRXP is part of Biotechnology industry that operates in the broader Healthcare sector. NRx Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of NRXP?

Mr. Stephen H. Willard Esq.
Chief Executive Officer & Director
Mr. Riccardo Panicucci
CMC & Technical Operations Advisor
Dr. Carrie Carretta Ph.D.
Senior Vice President of Clinical Devel. & Medical Affairs
Dr. Philip T. Lavin Ph.D.
Chief Methodologist
Dr. Seth L. Van Voorhees Ph.D.
Chief Financial Officer & Treasurer
Prof. Daniel C. Javitt
Co-Founder & Chairman of Scientific Advisory Board
Dr. Michael Kunz
Gen. Counsel & Corporation Sec.
Mr. Robert Besthof M.I.M.
Head of Operations, Chief Commercial & Patient Officer
Dr. Dennis K. McBride Ph.D.
Chief Strategy Officer & Senior Scientist
Dr. Jonathan C. Javitt M.D., M.P.H.
Co-Founder, Chief Scientist Officer & Director
Mr. Riccardo Panicucci Ph.D.
Chief Technology Officer
Ms. Molly Cogan
Senior Director of Global Communications & Gov. Affairs
Suzanne Messere
Investor Relations
Mr. Matthew Patrick Duffy
Chief Bus. Officer

How NRXP did perform over past 52-week?

NRXP's closing price is 97.27% higher than its 52-week low of $1.10 where as its distance from 52-week high of $7.20 is -69.86%.

How many employees does NRXP have?

Number of NRXP employees currently stands at 2.

Link for NRXP official website?

Official Website of NRXP is: https://www.nrxpharma.com

How do I contact NRXP?

NRXP could be contacted at phone 484 254 6134 and can also be accessed through its website. NRXP operates from 1201 Orange Street, Wilmington, DE 19801, United States.

How many shares of NRXP are traded daily?

NRXP stock volume for the day was 125.99K shares. The average number of NRXP shares traded daily for last 3 months was 1.21M.

What is the market cap of NRXP currently?

The market value of NRXP currently stands at $36.71M with its latest stock price at $2.17 and 16.92M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	2
Beta	1.22
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology